Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients
2016
Background Antidepressant-induced
liver injuryis a major concern and a liver monitoring scheme has been recommended by the European Medicines Agency for
agomelatine.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
48
References
17
Citations
NaN
KQI